SCLERODERMA
Clinical trials for SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA trials appear
Sign up with your email to follow new studies for SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame debilitating autoimmune disease
Disease control OngoingThis study is testing whether a medication called anifrolumab, given as a weekly injection, can safely help control the symptoms and slow the progression of systemic sclerosis (scleroderma). It will involve about 314 adults with a recent diagnosis of the disease. Participants wil…
Matched conditions: SCLERODERMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Tracking High-Risk pregnancies to unlock better care for women with rare diseases
Knowledge-focused TerminatedThis study aimed to gather information about pregnancy in women with rare autoimmune diseases like lupus and rheumatoid arthritis. Researchers planned to follow these pregnancies to understand complications and how medications affect both mother and baby. The goal was to use this…
Matched conditions: SCLERODERMA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC